Voliotis Dimitris
- SEC CIK
- 0001807910
No open-market purchases or sales filed in the past year.
Current role at each company
- ZNTL Zentalis Pharmaceuticals, Inc.SVP, Clinical Developmentas of Feb 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Voliotis Dimitris as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 (view filing) | Feb 14 | Same day | Voliotis DimitrisSVP, Clinical Development | SSale | −601 | $50.23 | −$30.2K | −3.6%16.0K after | 2 lots |
| Jan 20, 2022 (view filing) | Jan 18-20 | 2 days | Voliotis DimitrisSVP, Clinical Development | SSale | −30.0K | $61.36 | −$1.84M | −82.8%6.25K after | 9 lots |